Literature DB >> 24438053

Quantifying filariasis and malaria control activities in relation to lymphatic filariasis elimination: a multiple intervention score map (MISM) for Malawi.

Michelle C Stanton, Square Mkwanda, Themba Mzilahowa, Moses J Bockarie, Louise A Kelly-Hope.   

Abstract

OBJECTIVE: To quantify the geographical extent of filariasis and malaria control interventions impacting lymphatic filariasis (LF) in Malawi and to produce a multiple intervention score map (MISM) for prioritising surveillance and intervention strategies.
METHODS: Interventions included mass drug administration (MDA) for LF and onchocerciasis, and bed nets and indoor residual spraying (IRS) for malaria. District and subdistrict-level data were obtained from the Ministry of Health in Malawi, the Demographic and Health Survey (DHS) and President's Malaria Initiative reports. Single intervention scores were calculated for each variable based on population coverage thresholds, and these were combined in a weighted sum to form a multiple intervention score, which was then used to produce maps, that is MISMs. Districts were further classified into four groups based on the combination of their baseline LF prevalence and multiple intervention score.
RESULTS: The district- and subdistrict-level MISMs highlighted specific areas that have received high and low coverage of LF-impacting interventions. High coverage areas included the LF-onchocerciasis endemic areas in the southern region of the country and areas along the shores of Lake Malawi, where malaria vector control had been prioritised. Three districts with high baseline LF prevalence measures but low coverage of multiple interventions were identified and considered to be most at risk of ongoing transmission or re-emergence.
CONCLUSIONS: These maps and district classifications will be used by LF programme managers to identify and target high-risk areas that may not have received adequate LF-impacting interventions to interrupt the transmission of the disease.

Entities:  

Mesh:

Year:  2014        PMID: 24438053     DOI: 10.1111/tmi.12266

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  5 in total

1.  Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi.

Authors:  Terence Tafatatha; Miriam Taegtmeyer; Bagrey Ngwira; Amos Phiri; Mariot Kondowe; Wilson Piston; Anna Molesworth; Ndoliwe Kayuni; Olivier Koole; Amelia Crampin; John Horton; Neil French
Journal:  PLoS Negl Trop Dis       Date:  2015-06-04

2.  Fit for purpose: do we have the right tools to sustain NTD elimination?

Authors:  Lisa J Reimer; Emily R Adams; Mark Ji Paine; Hilary Ranson; Marlize Coleman; Edward K Thomsen; Eleanor E MacPherson; T Deirdre Hollingsworth; Louise A Kelly-Hope; Moses J Bockarie; Louise Ford; Robert A Harrison; J Russell Stothard; Mark J Taylor; Nicholas Hamon; Stephen J Torr
Journal:  BMC Proc       Date:  2015-12-18

3.  Measuring the physical and economic impact of filarial lymphoedema in Chikwawa district, Malawi: a case-control study.

Authors:  Michelle C Stanton; Masato Yamauchi; Square Z Mkwanda; Paul Ndhlovu; Dorothy Emmie Matipula; Charles Mackenzie; Louise A Kelly-Hope
Journal:  Infect Dis Poverty       Date:  2017-04-03       Impact factor: 4.520

4.  Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.

Authors:  Paula Moraga; Jorge Cano; Rebecca F Baggaley; John O Gyapong; Sammy M Njenga; Birgit Nikolay; Emmanuel Davies; Maria P Rebollo; Rachel L Pullan; Moses J Bockarie; T Déirdre Hollingsworth; Manoj Gambhir; Simon J Brooker
Journal:  Parasit Vectors       Date:  2015-10-24       Impact factor: 3.876

5.  A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings.

Authors:  Nicholas Riches; Xavier Badia-Rius; Themba Mzilahowa; Louise A Kelly-Hope
Journal:  PLoS Negl Trop Dis       Date:  2020-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.